Its therapeutic potential extends beyond managing hyperuricemia, demonstrating efficacy as a URAT1 and GLUT9 inhibitor, especially in cases of renal impairment
J Intern Med 282:284297
The sole instance where ipamorelins efficacy and safety were tested in a clinical setting was a small, 7-day-long, proof of concept study in 2014, involving just 114 participants [5]
doi: 10.1007/s10067-023-06578-9 [DOI] [PMC free article] [PubMed] [Google Scholar] 139.Ragab G, Elshahaly M, Bardin T
Estimation of the global disease burden of depression and anxiety between 1990 and 2044: an analysis of the global burden of disease study 2019
Genomics enables the mapping of quantitative trait loci (QTLs) and variants identified through genome-wide association studies (GWAS), revealing regulatory networks that coordinate nutrient transport and homeostasis under drought, salinity, cold, and heat stress